Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12611001005943Phase 4Not yet recruiting
Phase 4 trial of lidocaine in cancer (2 arms), sponsored by Palmerston North Hospital. Primary endpoint: Tumor recurrence. Planned start Oct 2011; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12611001005943.